Apothecary Pharma Llc: Tirzepatide Injection, 18mg/ml
Apothecary Pharma LLC is recalling Tirzepatide Injection 18mg/mL (a diabetes and weight-loss medication) because the company cannot confirm the product is sterile. The recall affects vials distributed nationwide across all U.S. states and Washington, D.C. This is a Class II recall, meaning use of the product could cause serious health problems.
- Recalling firm
- Apothecary Pharma LLC
- Product
- Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18.
- Reason
- Lack of Assurance of Sterility
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-09-24
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the United States
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/bacd7ed1-0bb5-493a-8196-1c52779497fc